产品描述:
MLN2480 is an orally bioavailable pan-Raf kinase inhibitor that inhibits MAP kinase pathway signaling in BRAF-mutant melanoma models.{31570} It shows antitumor activity in melanoma, colon, lung, and pancreatic cancer xenograft models.{31568} MLN2480 demonstrates synergistic activity with TAK-733, an allosteric MEK kinase inhibitor.{31567}